Progressive oxidative damage in the central nervous system of a murine model for juvenile batten disease

被引:20
作者
Benedict, Jared W.
Sommers, Crosby A.
Pearce, David A.
机构
[1] Univ Rochester, Sch Med & Dent, Ctr Aging & Dev Biol, Aab Inst Biomed Sci, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY USA
[3] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA
关键词
batten disease; neuronal ceroid lipofuscinosis; oxidative stress;
D O I
10.1002/jnr.21416
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Oxidative damage is a known contributor to the pathogenesis of neurodegenerative diseases. Juvenile Batten disease is a progressive neurodegenerative disorder of childhood that results from mutation in Cln3. We have performed an initial characterization of the oxidative burden throughout the CNS in a Cln3(-/-) mouse model for juvenile Batten disease. A survey of multiple regions of the Cln(-/-) mouse brain revealed a specific reduction of total glutathione, a tripeptide antioxidant molecule, in the cerebellum. Further analysis revealed an increase in protein oxidation not only in the cerebellum but also in the thalamus and primary motor cortex. Additionally, the thalamus was found to have an increase in the amount of a potent antioxidant enzyme, manganese superoxide dismutase (MnSOD), which may be in response to an increase in deleterious superoxide radicals. Colocalization studies indicate that microglia are localized directly adjacent to neurons expressing MnSOD, indicating that microglial activation may be related to the observed oxidative damage. This study helps to provide an initial measure of regions within the CNS of Cln3(-/-) mice that are specifically affected by the loss of CLN3 function and may serve to identify at the neuroanatomical level, the sequence of events that plays a role in the pathogenesis and clinical course of juvenile Batten disease. (c) 2007 Wiley-Liss, Inc.
引用
收藏
页码:2882 / 2891
页数:10
相关论文
共 51 条
[31]   Targeted disruption of the Cln3 gene provides a mouse model for Batten disease [J].
Mitchison, HM ;
Bernard, DJ ;
Greene, NDE ;
Cooper, JD ;
Junaid, MA ;
Pullarkat, RK ;
de Vos, N ;
Breuning, MH ;
Owens, JW ;
Mobley, WC ;
Gardiner, RM ;
Lake, BD ;
Taschner, PEM ;
Nussbaum, RL .
NEUROBIOLOGY OF DISEASE, 1999, 6 (05) :321-334
[32]   Glial cells mediate toxicity in glutathione-depleted mesencephalic cultures [J].
Mytilineou, C ;
Leonardi, ETK ;
Kramer, BC ;
Jamindar, T ;
Olanow, CW .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (01) :112-119
[33]   NEURONAL CEROID-LIPOFUSCINOSIS - A CLINICAL AND MORPHOLOGICAL-STUDY OF 19 PATIENTS [J].
NARDOCCI, N ;
VERGA, ML ;
BINELLI, S ;
ZORZI, G ;
ANGELINI, L ;
BUGIANI, O .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 57 (02) :137-141
[34]   Involvement of oxidative stress in Alzheimer disease [J].
Nunomura, Akihiko ;
Castellani, Rudy J. ;
Zhu, Xiongwei ;
Moreira, Paula I. ;
Perry, George ;
Smith, Mark A. .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2006, 65 (07) :631-641
[35]   Cell death pathways in juvenile Batten disease [J].
Persaud-Sawin, DA ;
Boustany, RMN .
APOPTOSIS, 2005, 10 (05) :973-985
[36]   Motifs within the CLN3 protein: modulation of cell growth rates and apoptosis [J].
Persaud-Sawin, DANW ;
VanDongen, A ;
Boustany, RMN .
HUMAN MOLECULAR GENETICS, 2002, 11 (18) :2129-2142
[37]   CLN3, the protein associated with batten disease: Structure, function and localization [J].
Phillips, SN ;
Benedict, JW ;
Weimer, JM ;
Pearce, DA .
JOURNAL OF NEUROSCIENCE RESEARCH, 2005, 79 (05) :573-583
[38]   Thalamocortical neuron loss and localized astrocytosis in the Cln3△ex7/8 knock-in mouse model of Batten disease [J].
Pontikis, CC ;
Cotman, SL ;
MacDonald, ME ;
Cooper, JD .
NEUROBIOLOGY OF DISEASE, 2005, 20 (03) :823-836
[39]   Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation [J].
Pontikis, CC ;
Cella, CV ;
Parihar, N ;
Lim, MJ ;
Chakrabarti, S ;
Mitchison, HM ;
Mobley, WC ;
Rezaie, P ;
Pearce, DA ;
Cooper, JD .
BRAIN RESEARCH, 2004, 1023 (02) :231-242
[40]   Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-synuclein transgenic mice -: a model of familial Parkinson's disease [J].
Poon, HF ;
Frasier, M ;
Shreve, N ;
Calabrese, V ;
Wolozin, B ;
Butterfield, DA .
NEUROBIOLOGY OF DISEASE, 2005, 18 (03) :492-498